Hedge Funds Are Buying Eli Lilly & Co. (LLY)

Page 1 of 2

Eli Lilly & Co. (NYSE:LLY) investors likely know every metric that’s typically discussed in relation to the healthcare giant, but we’ll shed light on a couple data points that you haven’t seen yet.

Now, according to many traders, hedge funds are seen as delayed, outdated investment tools of a period lost to current times. Although there are more than 8,000 hedge funds with their doors open in present day, Insider Monkey aim at the upper echelon of this group, around 525 funds. It is assumed that this group has its hands on the majority of the smart money’s total assets, and by watching their highest performing equity investments, we’ve determined a few investment strategies that have historically outpaced the S&P 500. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have trumped the S&P 500 index by 33 percentage points in 11 months (see all of our picks from August).

Equally as key, positive insider trading activity is a second way to analyze the investments you’re interested in. As the old adage goes: there are a variety of stimuli for an insider to sell shares of his or her company, but just one, very obvious reason why they would initiate a purchase. Plenty of academic studies have demonstrated the useful potential of this tactic if shareholders understand where to look (learn more here).

Now that that’s out of the way, it’s important to analyze the latest info surrounding Eli Lilly & Co. (NYSE:LLY).

What does the smart money think about Eli Lilly & Co. (NYSE:LLY)?

Heading into Q3, a total of 38 of the hedge funds we track held long positions in this stock, a change of 9% from the previous quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of notable hedge fund managers who were increasing their stakes meaningfully.

Eli Lilly & Co. (NYSE:LLY)Out of the hedge funds we follow, Renaissance Technologies, managed by Jim Simons, holds the biggest position in Eli Lilly & Co. (NYSE:LLY). Renaissance Technologies has a $605.5 million position in the stock, comprising 1.6% of its 13F portfolio. The second largest stake is held by Arrowstreet Capital, managed by Peter Rathjens Bruce Clarke and John Campbell, which held a $212.4 million position; the fund has 1.6% of its 13F portfolio invested in the stock. Some other hedge funds that are bullish include Cliff Asness’s AQR Capital Management, Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management and Israel Englander’s Millennium Management.

Consequently, certain money managers were breaking ground themselves. Renaissance Technologies, managed by Jim Simons, created the largest position in Eli Lilly & Co. (NYSE:LLY). Renaissance Technologies had 605.5 million invested in the company at the end of the quarter. Peter Rathjens Bruce Clarke and John Campbell’s Arrowstreet Capital also initiated a $212.4 million position during the quarter. The other funds with brand new LLY positions are Cliff Asness’s AQR Capital Management, Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management, and Israel Englander’s Millennium Management.

Insider trading activity in Eli Lilly & Co. (NYSE:LLY)

Insider buying is most useful when the primary stock in question has seen transactions within the past half-year. Over the latest 180-day time period, Eli Lilly & Co. (NYSE:LLY) has experienced zero unique insiders buying, and 5 insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Eli Lilly & Co. (NYSE:LLY). These stocks are Merck & Co., Inc. (NYSE:MRK), GlaxoSmithKline plc (ADR) (NYSE:GSK), Bristol Myers Squibb Co. (NYSE:BMY), AstraZeneca plc (ADR) (NYSE:AZN), and AbbVie Inc (NYSE:ABBV). This group of stocks belong to the drug manufacturers – major industry and their market caps resemble LLY’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!